HOXD10 and central nervous system cancer: In order to delve deeper into the transcriptional activity of HOXD10, the promoter sequences containing the wild type (Wt) and each possible binding site mutant (Mut) were inserted into the pGL4.20 plasmid and transfected into HOXD10 overexpression and control glioma cells (Figure 4E).